Cargando…
Tamoxifen blocks retrograde trafficking of Shiga toxin 1 and 2 and protects against lethal toxicosis
Shiga toxin 1 (STx1) and 2 (STx2), produced by Shiga toxin–producing Escherichia coli, cause lethal untreatable disease. The toxins invade cells via retrograde trafficking. Direct early endosome-to-Golgi transport allows the toxins to evade degradative late endosomes. Blocking toxin trafficking, par...
Autores principales: | Selyunin, Andrey S, Hutchens, Steven, McHardy, Stanton F, Mukhopadhyay, Somshuvra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Life Science Alliance LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599968/ https://www.ncbi.nlm.nih.gov/pubmed/31243048 http://dx.doi.org/10.26508/lsa.201900439 |
Ejemplares similares
-
Tamoxifen Derivatives Alter Retromer-Dependent Endosomal Tubulation and Sorting to Block Retrograde Trafficking of Shiga Toxins
por: Selyunin, Andrey S., et al.
Publicado: (2021) -
Genome-wide siRNA screen identifies UNC50 as a regulator of Shiga toxin 2 trafficking
por: Selyunin, Andrey S., et al.
Publicado: (2017) -
Targeting the Early Endosome-to-Golgi Transport of Shiga Toxins as a Therapeutic Strategy
por: Li, Danyang, et al.
Publicado: (2020) -
Shiga toxin–binding site for host cell receptor GPP130 reveals unexpected divergence in toxin-trafficking mechanisms
por: Mukhopadhyay, Somshuvra, et al.
Publicado: (2013) -
Functional Dissection of the Retrograde Shiga Toxin Trafficking Inhibitor Retro-2
por: Forrester, Alison, et al.
Publicado: (2020)